Postgraduate Course: Oncology 1 (UCHM12001)

Course Outline
School	Deanery of Clinical Sciences	College	College of Medicine and Veterinary Medicine
Credit level (Normal year taken)	SCQF Level 12 (Postgraduate)
Course type	Online Distance Learning	Availability	Not available to visiting students
SCQF Credits	15	ECTS Credits	7.5
Summary	The assessment and treatment of patients with urological malignancy
Course description	Review the pathophysiology of benign, malignant and premalignant urological tumors; Apply this knowledge and understanding to the systematic assessment and appropriate investigation of patients presenting with urological malignancy; Appraise the principles of neo-adjuvant therapy, and the principles and application of radiotherapy; identify indications for referral to specialist units and other colleagues for patients with urological cancer.

Entry Requirements (not applicable to Visiting Students)
Pre-requisites		Co-requisites
Prohibited Combinations		Other requirements	None

Course Delivery Information

Academic year 2024/25, Not available to visiting students (SS1)		Quota: None
Course Start	Full Year
Timetable	Timetable
Learning and Teaching activities (Further Info)	Total Hours: 150 ( Online Activities 95, Feedback/Feedforward Hours 2, Summative Assessment Hours 3, Programme Level Learning and Teaching Hours 3, Directed Learning and Independent Learning Hours 47 )
Assessment (Further Info)	Written Exam 60 %, Coursework 40 %, Practical Exam 0 %
Additional Information (Assessment)	Written Exam 60%, coursework 40%, Practical Exam 0%
Feedback	Not entered
No Exam Information

Learning Outcomes
Review the pathophysiology of benign, malignant and premalignant urological tumours; Apply this knowledge and understanding to the systematic assessment and appropriate investigation of patients presenting with urological malignancy; Appraise the principles of neo-adjuvant versus adjuvant therapy, and the principles and application of radiotherapy; Identify indications for referral to specialist units and other colleagues for patients with urological cancer.